A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer. Researchers discuss the findings.

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the cutting edge to detect and prevent ovarian cancer.

Taking aspirin was first linked to a lower risk of colorectal cancer in 1988, but the research into its anti-tumour potential has been full of twists and turns since then

About 55% of people assigned a patient navigator got a follow-up colonoscopy after their stool test revealed a risk of colon cancer, compared with nearly 43% of patients who were simply notified of the abnormal test and given a referral, researchers reported March 31 in the Annals of Internal Medicine.

Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a type of ovarian cancer without the disease getting worse in a late-stage trial,

The former 'Dancing with the Stars'' host's days now consist of planning for upcoming Your Healthiest Healthy retreats and 'booby PT' — and spending quality time with her family and friends whenever p

It may seem unusual to discuss future fertility when a family is reeling from the diagnosis of a child’s cancer. But 85% of children with cancer now survive to adulthood and about 1 in 3 are left infertile from chemotherapy or radiation.

Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type of ovarian cancer in a late-stage trial.

In an intention-to-screen population, participation in any form of screening was 31.8% in the colonoscopy group and 39.9% in the FIT group (risk ratio [RR] 0.79, 95% CI 0.77-0.82), reported Antoni Castells, MD, of the University of Barcelona, and colleagues in The Lancet.